I won't name the pharma directly but will say that after a certain merger I believe they became "the biggest one in the world." I wasn't employed by them directly but by a third party vendor that was doing work for them. I was greatly impressed by how strictly they followed protocol and how they insisted that others with whom they were working had to meet the same exacting standards regarding processes. I'm sure Abbott as an industry leader in diagnostics is comparable: the pharma companies are all under tremendous and relentless scrutiny from regulatory agencies in the US and elsewhere. They work hard to ensure their products are thoroughly tested and as safe as possible. It's not a game for them; they are very serious players. So I'm not surprised Abbott isn't talking to an unknown penny stock investor who is phoning them with questions about a product in development. (No offence Bocxman!)
I also suspect that Biocurex people will be feeling the pressure to ensure that their own corporate processes are formalized. And this pressure will increase the more licensees sign up.
News 
Market Data 
Discover 
